{
    "clinical_study": {
        "@rank": "42132", 
        "arm_group": [
            {
                "arm_group_label": "A.", 
                "arm_group_type": "Experimental", 
                "description": "Patients will be stratified according to the use of prophylactic antibiotics.    Both groups may receive open-label gram-negative coverage with either ceftazidime, aztreonam, and/or aminoglycosides (gentamicin, tobramycin, amikacin).  Subjects will receive study medication intravenously every 12 hours for 7 to 28 days."
            }, 
            {
                "arm_group_label": "B.", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will treat patients who have fever and neutropenia (after cancer chemotherapy)\n      that is possibly due to a specific bacteria (gram positive bacteria)."
        }, 
        "brief_title": "Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection", 
        "completion_date": {
            "#text": "November 2002", 
            "@type": "Actual"
        }, 
        "condition": "Febrile Neutropenia", 
        "condition_browse": {
            "mesh_term": [
                "Fever", 
                "Neutropenia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients must have neutropenia (ANC less than 500) with fever (oral temp 38.3 C).\n\n        Patients must have a cancer with recent chemotherapy and risks factors for gram positive\n        infections.\n\n        Exclusion Criteria:\n\n        Patients with fever due to known causes. Patients with HIV. Patients with recent bone\n        marrow transplant. Patients with an infected indwelling catheter that cannot be removed.\n        Patients who have received more than one day of another antibiotic before entering the\n        trial.\n\n        Patients with endocarditis, osteomyelitis, meningitis, CNS infections."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 3, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00035425", 
            "org_study_id": "M12600079", 
            "secondary_id": "A5951059"
        }, 
        "intervention": [
            {
                "arm_group_label": "A.", 
                "description": "600mg every 12 hours", 
                "intervention_name": "linezolid", 
                "intervention_type": "Drug", 
                "other_name": "Zyvox"
            }, 
            {
                "arm_group_label": "B.", 
                "description": "1gm every 12 hours. The dose of vancomycin intravenously may be adjusted for renal function, but the patient must be able to receive a 300 mL volume of intravenous fluid at the assigned dosing times of every 12 hours.", 
                "intervention_name": "vancomycin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vancomycin", 
                "Linezolid"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 30, 2009", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=M12600079&StudyName=Treatment%20of%20Neutropenic%20Patients%20With%20Fever%20Who%20Are%20Suspected%20to%20Have%20A%20Gram%20Positive%20Infection%20"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62701-1014"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62703"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62769"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62781"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10461"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23249"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23226"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23229"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23294"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23294-4367"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Federal Way", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98003"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lakewood", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98499"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacoma", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98405"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Argentina", 
                        "state": "C\u00f3rdoba", 
                        "zip": "5000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1094"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Argentina", 
                        "zip": "5000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mendoza", 
                        "country": "Argentina", 
                        "zip": "5500"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90020-090"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90610-000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "01509-900"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "01409-902"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "zip": "05651-901"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "zip": "04024-002"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bogota", 
                        "country": "Colombia", 
                        "state": "Bogota. DC"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bogota", 
                        "country": "Colombia", 
                        "state": "Bogota. DC", 
                        "zip": "NAP"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medellin", 
                        "country": "Colombia"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland", 
                        "zip": "FIN-00029 HYKS"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zapopan", 
                        "country": "Mexico", 
                        "state": "Jalisco", 
                        "zip": "45173"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "state": "Nuevo Leon", 
                        "zip": "C.P. 64000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico D.f.", 
                        "country": "Mexico", 
                        "zip": "C.P. 02990"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lahore", 
                        "country": "Pakistan", 
                        "state": "Punjab"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karachi", 
                        "country": "Pakistan", 
                        "zip": "74800"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lima", 
                        "country": "Peru", 
                        "zip": "13"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lima", 
                        "country": "Peru", 
                        "zip": "34"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela", 
                        "state": "Distrito Federal", 
                        "zip": "1041"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela", 
                        "zip": "1020"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Brazil", 
                "Chile", 
                "Colombia", 
                "Finland", 
                "Mexico", 
                "Pakistan", 
                "Peru", 
                "Venezuela"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": {
            "measure": "Clinical efficacy of linezolid when administered intravenously as compared to intravenously administered vancomycin in the empiric treatment of oncology patients with febrile neutropenia with suspected gram-positive infections.", 
            "safety_issue": "No", 
            "time_frame": "7-28 days"
        }, 
        "removed_countries": {
            "country": "Puerto Rico"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00035425"
        }, 
        "responsible_party": {
            "name_title": "Director, Clinical Trial Disclosure Group", 
            "organization": "Pfizer, Inc."
        }, 
        "secondary_outcome": [
            {
                "measure": "Microbiologic outcome", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Pathogen eradication (eradication rates of individual pathogens)", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Defervescence (defined as Tmax orally or rectally)", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Time to defervescence", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Resolution of neutropenia (return of ANC to >500 cells/mm3)", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Time to resolution of neutropenia", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }, 
            {
                "measure": "Mortality rate (survival at 7 days after the end of therapy)", 
                "safety_issue": "No", 
                "time_frame": "7-28 days"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2009"
    }, 
    "geocoordinates": {
        "Pfizer Investigational Site": "10.491 -66.902"
    }
}